back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-05 17:16 Tx date 2025-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$489,999
+350,000 vol $1.40 each |
675,000 | |
| Filed 2025-10-22 16:03 Tx date 2025-10-17 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$67,500
+50,000 vol $1.35 each |
50,000 | |
| Filed 2025-10-22 16:00 Tx date 2025-10-17 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
11 - Acquisition or disposition carried out privately
|
$100,000
+100,000 vol $1.00 each |
1,344,500 | |
| Filed 2025-10-03 17:10 Tx date 2025-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,979 vol |
413,979 | |
| Filed 2024-12-17 08:29 Tx date 2024-12-16 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$75,072
+40,000 vol $1.88 each |
1,244,500 | |
| Filed 2024-07-12 17:56 Tx date 2024-07-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+357,000 vol |
357,000 | |
| Filed 2024-07-12 17:54 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-24 13:59 Tx date 2024-06-24 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$138,490
+50,000 vol $2.77 each |
1,204,500 | |
| Filed 2022-07-08 16:06 Tx date 2022-07-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-600,000 vol |
1,154,500 | |
| Filed 2022-06-24 16:47 Tx date 2022-06-23 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
73 - Expiration of third party derivative
|
+1 vol |
0 | |
| Filed 2021-12-14 17:52 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,166,750
+325,000 vol $3.59 each |
325,000 | |
| Filed 2021-12-14 17:49 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-14 20:25 Tx date 2021-09-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-200,000 vol |
1,754,500 | |
| Filed 2021-05-25 17:06 Tx date 2021-05-25 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-48,000
-15,000 vol $3.20 each |
1,954,500 | |
| Filed 2021-02-10 20:09 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-190,001.50
-58,462 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 20:06 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$190,001
+58,462 vol $3.25 each |
2,027,962 | |
| Filed 2021-02-10 20:03 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-190,001.50
-58,462 vol $3.25 each |
0 | |
| Filed 2021-02-10 19:57 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-199,998.50
-61,538 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 19:53 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$199,998
+61,538 vol $3.25 each |
2,031,038 | |
| Filed 2021-02-10 19:47 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-199,998.50
-61,538 vol $3.25 each |
58,462 |